The Chemours Company Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	5,808	5,782	6,078	6,831	6,345
Revenue Growth (YoY)	0.45%	-4.87%	-11.02%	7.66%	27.69%
Cost of Revenue	4,899	4,640	4,736	5,215	4,964
Gross Profit	909	1,142	1,342	1,616	1,381
Selling, General & Admin	504	595	1,286	705	583
Research & Development	108	109	108	118	107
Operating Expenses	612	704	1,394	823	690
Operating Income	297	438	-52	793	691
Interest Expense	-269	-263	-208	-163	-185
Earnings From Equity Investments	35	43	45	55	43
Currency Exchange Gain (Loss)	-11	-9	-38	-15	3
Other Non Operating Income (Expenses)	19	11	19	57	36
EBT Excluding Unusual Items	71	220	-234	727	588
Merger & Restructuring Charges	-81	-60	-193	-16	-6
Impairment of Goodwill	-	-56	-	-	-
Gain (Loss) on Sale of Assets	8	3	110	23	115
Legal Settlements	-270	-	-	-	-
Other Unusual Items	-5	-1	-1	7	-21
Pretax Income	-277	106	-318	741	676
Income Tax Expense	109	37	-66	163	68
Earnings From Continuing Operations	-386	69	-252	578	608
Minority Interest in Earnings	-	-	-1	-	-
Net Income	-386	69	-253	578	608
Net Income to Common	-386	69	-253	578	608
Net Income Growth	-	-	-	-4.93%	177.63%
Shares Outstanding (Basic)	150	149	149	155	165
Shares Outstanding (Diluted)	150	150	149	158	169
Shares Change (YoY)	0.04%	0.85%	-5.93%	-6.16%	1.41%
EPS (Basic)	-2.57	0.46	-1.70	3.72	3.69
EPS (Diluted)	-2.57	0.46	-1.70	3.65	3.60
EPS Growth	-	-	-	1.39%	172.73%
Free Cash Flow	51	-993	186	448	537
Free Cash Flow Per Share	0.34	-6.61	1.25	2.83	3.18
Dividend Per Share	0.512	1.000	1.000	1.000	1.000
Dividend Growth	-48.75%	-	-	-	-
Gross Margin	15.65%	19.75%	22.08%	23.66%	21.77%
Operating Margin	5.11%	7.58%	-0.86%	11.61%	10.89%
Profit Margin	-6.65%	1.19%	-4.16%	8.46%	9.58%
Free Cash Flow Margin	0.88%	-17.17%	3.06%	6.56%	8.46%
EBITDA	637	730	257	1,084	1,008
EBITDA Margin	10.97%	12.63%	4.23%	15.87%	15.89%
D&A For EBITDA	340	292	309	291	317
EBIT	297	438	-52	793	691
EBIT Margin	5.11%	7.58%	-0.85%	11.61%	10.89%
Effective Tax Rate	-	34.91%	-	22.00%	10.06%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q